$PPCB

2 stories mentioning PPCB

Every FINWIRES story that references PPCB, newest first.

Top Midday Gainers

Propanc Biopharma (PPCB) approved a share repurchase program to buy back up to $5 million of common stock, the company said Thursday.Shares soared 124% as intraday trading volume catapulted to over 155.6 million from a daily average of about 130,000.Adial Pharmaceuticals (ADIL) said Thursday it has acquired Azora Therapeutics, a biopharmaceutical company developing treatments for serious inflammatory diseases.Shares soared 30% amid a surge in intraday trading volume to over 16.5 million from a daily average of roughly 118,000.Applied Materials (AMAT) expanded manufacturing and research & development operations in Singapore with a $500 million facility in Tampines to support AI-driven semiconductor demand.Shares jumped 8.5% following an increase in intraday trading volume to over 5.3 million from a daily average of about 7 million.Price: $3.04, Change: $+1.69, Percent Change: +124.81%

$ADIL$AMAT$PPCB

Wire4d ago

Propanc Biopharma Authorizes $5 Million Stock Buyback Program; Shares Jump

Propanc Biopharma (PPCB) said Thursday it approved a share repurchase program allowing it to buy back up to $5 million of its common stock.Under the program, Propanc Biopharma may repurchase shares from time to time in amounts, at prices and at times it deems appropriate, subject to market conditions, the company said.Propanc said the company "is entering a transformative stage with a novel, first-in-class cancer therapy for treatment & prevention of metastatic cancer from solid tumors."Propanc Biopharma shares were more than 250% higher in Thursday trading.Price: $5.33, Change: $+3.98, Percent Change: +294.81%

$PPCB